Related Experiment Video
Updated: May 20, 2026

05:11
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
Published on: January 2, 2026
Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy
Matthias Hassenpflug1, Werner Hartwig, Oliver Strobel
1Department of General Surgery, University of Heidelberg, Heidelberg, Germany.
Surgery
|July 24, 2012
Summary
Coverage of the pancreatic remnant after distal pancreatectomy significantly reduces pancreatic fistulas and lowers hospital costs. This technique improves patient outcomes and reduces length of stay, offering a valuable approach for managing pancreatic stump closure.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Abdominal Surgery
Background:
- Distal pancreatectomy carries a high risk of pancreatic fistula (up to 60%).
- Optimal management of the pancreatic stump after distal pancreatectomy remains debated.
- Autologous tissue coverage of the pancreatic resection margin is an alternative technique.
Purpose of the Study:
- To evaluate the clinical benefits of autologous tissue coverage for the pancreatic resection margin.
- To assess the impact of coverage on pancreatic fistula rates and treatment costs.
Main Methods:
- Prospective evaluation of 117 patients undergoing distal pancreatectomy (May 2009-Sept 2010).
- 73 patients received a pancreatic stump coverage procedure; 44 served as controls.
- Focus on International Study Group on Pancreatic Fistula criteria and treatment cost analysis.
Main Results:
- Clinically relevant pancreatic fistulas (Types B and C) were significantly reduced with coverage (7% vs. 25% for Type C, P < .002).
- Patients with coverage experienced shorter hospital stays (P < .02).
- Coverage procedure led to lower treatment costs (P < .001).
Conclusions:
- Coverage of the pancreatic remnant after distal pancreatectomy reduces clinically relevant fistulas.
- This technique also decreases hospital duration of stay and treatment costs.
- Further randomized trials are recommended to confirm these findings.
